Filtros de búsqueda

Lista de obras de

17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes

artículo científico publicado en 2000

4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion

scientific article published on 01 April 2019

5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study

artículo científico publicado en 1991

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast ⬇️

artículo científico publicado el 2 de mayo de 2013

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

artículo científico publicado en 2003

A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer

artículo científico publicado el 1 de enero de 1981

A comprehensive analysis of breast cancer microbiota and host gene expression.

artículo científico publicado en 2017

A comprehensive examination of CYP19 variation and breast density

artículo científico publicado en 2007

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches

artículo científico publicado en 2006

A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.

artículo científico publicado en 2010

A design for phase II testing of anticancer agents within a phase III clinical trial ⬇️

artículo científico publicado el 1 de junio de 1988

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

artículo científico publicado en 1991

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

artículo científico publicado en 2006

A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis

artículo científico publicado en 2007

A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations

artículo científico publicado en 2007

A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma

artículo científico publicado en 2007

A phase I study of chlorozotocin (NSC 178248)

artículo científico publicado el 1 de junio de 1979

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

artículo científico publicado en 2007

A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms

artículo científico publicado en 1984

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

artículo científico publicado en 2000

A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study

artículo científico publicado en 2005

A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.

artículo científico publicado en 2005

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer

scientific article published on 01 November 1984

A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinoma

scientific article published on 01 June 1996

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.

artículo científico publicado en 2015

A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.

artículo científico publicado en 1982

A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites

artículo científico publicado en 2010

A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma

artículo científico publicado en 1989

A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma ⬇️

artículo científico publicado el 15 de julio de 1997

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer

artículo científico publicado en 2002

A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer.

artículo científico publicado en 1991

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

artículo científico publicado en 2003

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

scientific article published on 01 March 1999

A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women

scientific article published on 09 January 2011

A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer

scientific article published on 01 January 1980

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

artículo científico publicado en 2006

Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts ⬇️

artículo científico publicado el 1 de noviembre de 2010

Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study

artículo científico publicado en 1997

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

artículo científico publicado en 2009

Adjuvant ovarian suppression in premenopausal breast cancer

artículo científico publicado en 2014

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

artículo científico publicado en 2003

American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting ⬇️

artículo científico publicado el 5 de mayo de 2003

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

artículo científico publicado en 2000

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

artículo científico publicado en 2004

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

artículo científico publicado en 2002

An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advances breast cancer undergoing oophorectomy: a later analysis

artículo científico publicado en 1982

An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancer

artículo científico publicado el 1 de enero de 1981

An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer

artículo científico publicado en 1980

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer ⬇️

artículo científico publicado el 1 de julio de 1997

An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk

artículo científico publicado en 2013

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

artículo científico publicado en 2019

Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor α

artículo científico publicado en 2020

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

scientific article published on 19 May 2020

Aromatase immunoreactivity is increased in mammographically dense regions of the breast

artículo científico publicado en 2010

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics

artículo científico publicado en 2014

Aromatase inhibitors for therapy of advanced breast cancer

artículo científico publicado en 2005

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings ⬇️

artículo científico publicado el 1 de septiembre de 2003

Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression ⬇️

artículo científico publicado el 9 de marzo de 2012

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

artículo científico publicado en 2005

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

artículo científico publicado en 2020

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

artículo científico publicado en 2009

Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells

artículo científico publicado en 2014

Aurora-A overexpression is linked to development of aggressive teratomas derived from humans iPS cells

artículo científico publicado en 2018

Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record ⬇️

artículo científico publicado el 1 de diciembre de 2011

BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study

article

Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial

artículo científico publicado en 2020

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

artículo científico publicado en 2008

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

artículo científico publicado en 2015

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

article

Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes

artículo científico publicado en 2017

Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms

artículo científico publicado en 2008

Breast cancer survival and the timing of tumor removal during the menstrual cycle ⬇️

artículo científico publicado el 1 de noviembre de 1997

Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience

artículo científico publicado en 1994

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

artículo científico publicado en 2011

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

artículo científico publicado en 2011

CYP2D6 and Tamoxifen: Awaiting the Denouement ⬇️

artículo científico publicado el 31 de octubre de 2011

CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations

artículo científico publicado en 2013

CYP2D6 genotype and tamoxifen response

artículo científico publicado en 2005

CYP2D6 genotype and tamoxifen: considerations for proper nonprospective studies

artículo científico publicado en 2014

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. ⬇️

artículo científico publicado en 2012

Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion

artículo científico publicado en 2017

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

artículo científico publicado en 2008

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention

artículo científico publicado en 2006

Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity ⬇️

artículo científico publicado el 17 de marzo de 1998

Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen

scientific article published on 01 June 1981

Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapy

artículo científico publicado en 1980

Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer

artículo científico publicado en 1983

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

artículo científico publicado en 2018

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

scientific article published on 06 May 2020

Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer

artículo científico publicado en 2006

Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer

artículo científico publicado en 1999

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

artículo científico publicado en 1991

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma

artículo científico publicado en 2006

Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

artículo científico publicado en 1996

Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer

artículo científico publicado en 2008

Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27.

artículo científico publicado en 2016

Competing risks of death in younger and older postmenopausal breast cancer patients

artículo científico publicado en 2014

Complications of therapy and a diagnostic dilemma case. Case 3. Diagnostic dilemma: sarcoidosis simulating metastatic malignancy

artículo científico publicado en 2003

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

scientific article published on 01 June 2002

Coprescription of tamoxifen and medications that inhibit CYP2D6.

artículo científico publicado en 2010

Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model

artículo científico publicado en 2007

Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers

artículo científico publicado el 1 de mayo de 1981

Cyclophosphamide, Doxorubicin, and Cisplatin Combined in the Treatment of Advanced Sarcomas ⬇️

artículo científico publicado el 1 de enero de 1983

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

artículo científico publicado en 1981

Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance

artículo científico publicado en 2008

DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication

scientific article published on 01 October 1991

DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials

artículo científico

DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer

artículo científico publicado en 1994

Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example

scientific article published on 03 May 2007

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

scientific article published on 01 October 2019

Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model

artículo científico publicado en 2009

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

artículo científico publicado en 2002

Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody

scientific article published on February 2012

Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.

artículo científico publicado en 2004

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR

scientific article published on 01 June 2002

Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

artículo científico publicado en 2002

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

article

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer

artículo científico publicado en 2017

ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis

article published in the Proceedings of the National Academy of Sciences of the United States of America

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

artículo científico publicado en 2014

Early Clinical Study of an Intermittent Schedule for Maytansine (NSC-153858): Brief Communication 2 ⬇️

artículo científico publicado el 1 de enero de 1978

Early discontinuation of tamoxifen: a lesson for oncologists

artículo científico publicado en 2007

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

artículo científico publicado en 1987

Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

scientific article published on 01 September 2004

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17

scientific article published on 05 July 2006

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.

artículo científico publicado en 2018

Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial

artículo científico publicado en 2014

Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17

article

Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study

artículo científico publicado en 2004

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

artículo científico publicado en 2008

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

artículo científico publicado en 2016

Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference

artículo científico publicado en 2008

Endocrine therapy in 2009: consideration of the tumor and the host.

artículo científico publicado en 2009

Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens

artículo científico publicado en 2013

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

artículo científico publicado en 2017

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects

artículo científico publicado en 2009

Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells

artículo científico

Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain

artículo científico publicado en 2008

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

artículo científico publicado en 2022

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

artículo científico publicado en 2011

Estrogen receptors in patients with malignant melanoma

scientific article published on 01 October 1980

Estrogen replacement therapy withdrawal and regression of metastatic breast cancer

artículo científico publicado en 1995

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation

artículo científico publicado en 2016

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

artículo científico publicado en 2014

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials

artículo científico publicado en 2011

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

artículo científico publicado en 2015

Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer

artículo científico publicado el 1 de julio de 1981

Evaluation of a fixed alternating treatment in patients with advanced breast cancer

artículo científico publicado el 1 de enero de 1978

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

artículo científico publicado en 2005

Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancer

artículo científico publicado el 1 de noviembre de 1981

Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer

artículo científico publicado en 1986

Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins

scientific article published on 01 October 1997

Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer

artículo científico publicado en 1995

Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer

artículo científico publicado en 1997

Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure

artículo científico publicado en 1989

Evaluation of mitolactol in women with advanced breast cancer and prior chemotherapy exposure

scientific article published on 01 October 1983

Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy

artículo científico publicado en 1994

Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk ⬇️

artículo científico publicado el 24 de febrero de 2012

Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer

scientific article published on 01 July 1999

Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder

artículo científico publicado en 2014

Evaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposure

artículo científico publicado en 1990

Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer

scientific article published on 01 May 1984

Exemestane for breast-cancer prevention in postmenopausal women

artículo científico publicado en 2011

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

artículo científico publicado en 2013

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

artículo científico publicado en 2015

Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus

artículo científico publicado en 2012

Extended adjuvant endocrine therapy in breast cancer: current status and future directions

artículo científico publicado en 2008

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

artículo científico publicado en 2016

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

artículo científico publicado en 2017

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients

artículo científico publicado en 2020

Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.

artículo científico publicado en 2006

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

artículo científico publicado en 2010

Functional genomics based on germline genome-wide association studies of endocrine therapy for breast cancer

artículo científico publicado en 2020

Functional role of KLF10 in multiple disease processes

artículo científico publicado en 2010

Gene-Expression–Based Predictors for Breast Cancer

article

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

artículo científico publicado en 2016

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

artículo científico publicado en 2013

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

artículo científico publicado en 2010

Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

artículo científico publicado en 2018

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

article

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial

artículo científico publicado en 2010

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

artículo científico publicado en 2006

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization

scientific article published on 01 February 2002

Heat shock protein inhibitors increase the efficacy of measles virotherapy

artículo científico publicado en 2008

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.

artículo científico publicado en 2009

Identification of a novel percent mammographic density locus at 12q24.

artículo científico publicado en 2012

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

artículo científico publicado en 2009

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

artículo científico publicado en 2009

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

artículo científico publicado en 2017

Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

artículo científico publicado en 2013

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

artículo científico publicado en 2017

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole ⬇️

artículo científico publicado el 1 de octubre de 2012

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

artículo científico publicado en 2003

In Reply:

Increased HER2 with U.S. Food and Drug Administration-approved antibody

artículo científico publicado en 1999

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials

scientific article published on 01 November 1996

Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.

artículo científico publicado en 2013

Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.

artículo científico publicado en 2014

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.

artículo científico publicado en 2015

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

artículo científico publicado en 2007

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.

artículo científico publicado en 2008

Introduction to session on undue and disproportionate influences ⬇️

artículo científico publicado el 20 de diciembre de 2010

Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression

artículo científico publicado en 2018

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen

artículo científico publicado en 2008

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study ⬇️

artículo científico publicado el 23 de octubre de 2012

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group

artículo científico publicado en 2009

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

artículo científico publicado en 2014

Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development

artículo científico publicado en 1999

MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

Malignant, predominantly lymphocytic thymoma with central and peripheral nervous system metastases

artículo científico publicado en 1981

Mammographic breast density response to aromatase inhibition

artículo científico publicado en 2013

Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study

artículo científico publicado en 2009

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

artículo científico publicado en 2019

Metaplastic breast cancer: prognosis and response to systemic therapy

artículo científico publicado en 1999

Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer

artículo científico publicado en 2006

Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer

artículo científico publicado en 1997

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy

artículo científico publicado en 2008

Molecular markers in male breast carcinoma

artículo científico publicado en 1998

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells

artículo científico publicado en 2017

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

artículo científico publicado en 2016

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study ⬇️

artículo científico publicado el 1 de marzo de 1998

Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome

artículo científico publicado en 2010

NOTCH3 expression is linked to breast cancer seeding and distant metastasis

scientific article published on 04 September 2018

National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: evaluation of exemestane to prevent breast cancer in postmenopausal women

artículo científico publicado en 2007

Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

artículo científico publicado en 2014

Octreotide as first-line treatment for women with metastatic breast cancer

scientific article published on 01 January 1996

Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues

scientific article published on 30 September 2019

Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.

artículo científico publicado en 2017

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

artículo científico publicado en 2009

PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient

scientific article published on 01 December 2018

Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors

scientific article published on 01 August 1993

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization

artículo científico publicado en 2006

Pericardial effusion in women with breast cancer

scientific article published on 01 July 1987

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

artículo científico publicado en 2005

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study

artículo científico publicado en 2017

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

scientific article published on 23 July 2020

Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

artículo científico publicado en 2015

Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.

artículo científico publicado en 1999

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.

artículo científico publicado en 2017

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer ⬇️

artículo científico publicado el 21 de agosto de 2013

Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancer.

artículo científico publicado en 1983

Phase II evaluation of AMSA in patients with metastatic lung cancer

artículo científico publicado en 1980

Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanoma

artículo científico publicado en 1981

Phase II evaluation of PALA in patients with metastatic lung cancer

artículo científico publicado el 1 de marzo de 1981

Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma

artículo científico publicado el 1 de noviembre de 1979

Phase II evaluation of maytansine in patients with advanced head and neck cancer

artículo científico publicado el 1 de noviembre de 1979

Phase II evaluation of maytansine in patients with metastatic lung cancer

scientific article published on 01 October 1978

Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy

scientific article published on 01 October 1988

Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung

artículo científico publicado en 1980

Phase II evaluation of triazinate in patients with metastatic lung cancer

artículo científico publicado en 1980

Phase II study of chlorozotocin in advanced breast cancer

scientific article published on 01 May 1981

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

artículo científico publicado el 1 de septiembre de 1979

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial

artículo científico publicado en 2005

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

artículo científico publicado en 1982

Phase II study of tamoxifen in patients with disseminated malignant melanoma

scientific article published on 01 February 1980

Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.

artículo científico publicado en 1981

Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy

artículo científico publicado el 1 de mayo de 1978

Phase II study on DON in patients with previously treated advanced lung cancer

artículo científico publicado el 1 de agosto de 1982

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group

artículo científico publicado en 2014

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology

artículo científico publicado en 2010

Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307

scientific article published on 31 October 2019

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

artículo científico publicado en 2003

Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen

scientific article published on 04 December 2006

Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196

artículo científico publicado en 2006

Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer

artículo científico publicado el 1 de octubre de 1977

Postchemotherapy rheumatism

artículo científico publicado en 1993

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker ⬇️

artículo científico publicado el 28 de junio de 2013

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

artículo científico publicado en 2006

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement

artículo científico publicado en 2006

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.

artículo científico publicado en 2005

Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

artículo científico publicado en 2004

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

artículo científico publicado en 2010

Prognostic factors for patients with carcinoma of the breast

artículo científico publicado en 1995

Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trials

artículo científico publicado en 1996

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol

scientific article published on 01 December 1994

Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancer

artículo científico publicado en 1988

Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.

artículo científico publicado en 1982

Providing Balance in ASCO Clinical Practice Guidelines: CYP2D6 Genotyping and Tamoxifen Efficacy

scientific article published on 01 November 2016

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years

artículo científico publicado en 2018

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer

artículo científico publicado en 2014

Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells ⬇️

artículo científico publicado el 19 de marzo de 2012

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

article

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer

artículo científico publicado en 1989

Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer

artículo científico publicado en 1985

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer

artículo científico publicado en 1981

Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure

artículo científico publicado en 1985

Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer

scientific article published on 01 April 1982

Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer

artículo científico publicado en 1988

Randomized double‐blind phase 2 trial of 3 doses of TAS‐108 in patients with advanced or metastatic postmenopausal breast cancer ⬇️

artículo científico publicado el 1 de julio de 2012

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both

artículo científico publicado en 2004

Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer

artículo científico publicado el 1 de noviembre de 1979

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

artículo científico publicado en 2004

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer

artículo científico publicado en 1986

Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer

scientific article published on 01 May 1994

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis

artículo científico publicado en 1999

Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.

artículo científico publicado en 1989

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

artículo científico publicado en 2005

Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer

artículo científico publicado en 1988

Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer

scientific article published on 01 June 1986

Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.

artículo científico publicado en 2006

Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung ⬇️

artículo científico publicado el 1 de agosto de 1979

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

artículo científico publicado en 1989

Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors

artículo científico publicado en 2008

Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

artículo científico publicado en 2014

Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer

artículo científico publicado en 1978

Reply to A.-S. Dieudonné et al and J.M. Rae et al.

artículo científico publicado en 2013

Reply to C. Shah et al.

artículo científico publicado en 2016

Reply to P. Niravath et Al.

artículo científico publicado en 2014

Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer

scientific article published on 01 March 1989

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

scientific article published on 15 September 2020

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway

artículo científico publicado en 2017

SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1

artículo científico publicado en 2017

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen

artículo científico publicado en 2011

Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.

artículo científico publicado en 2003

Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF423 Regulation of BRCA1 Expression: Individualized Breast Cancer Prevention ⬇️

artículo científico publicado el 13 de junio de 2013

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).

artículo científico publicado en 2007

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer ⬇️

artículo científico publicado el 31 de octubre de 2011

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole

artículo científico publicado en 2005

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer

artículo científico publicado en 2020

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats

artículo científico publicado en 2017

Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors

scientific article published on 01 July 2001

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

artículo científico publicado en 2015

Systemic Adjuvant Therapy in Women With Resected Node-Negative Breast Cancer ⬇️

artículo científico publicado el 1 de agosto de 1991

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors

scientific article published on 01 July 2002

TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune

scientific article published on 14 June 2017

TCL1A, a novel transcription factor and a co-regulator of NF-кB p65: SNP and estrogen-dependence

artículo científico publicado en 2018

TGFβ inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton

artículo científico publicado en 2014

TGFβ/TNFα-Mediated Epithelial–Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype ⬇️

artículo científico publicado el 9 de mayo de 2011

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

artículo científico publicado en 2013

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

artículo científico publicado en 2018

Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM

artículo científico publicado en 2019

Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters

artículo científico publicado en 2012

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug

artículo científico publicado en 1987

The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton

artículo científico publicado en 2014

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

artículo científico publicado en 2006

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

artículo científico publicado en 2005

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

The molecular etiology of breast cancer: evidence from biomarkers of risk

artículo científico publicado en 2008

The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells

artículo científico publicado en 2009

Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer

artículo científico publicado el 1 de enero de 1981

Tissue composition of mammographically dense and non-dense breast tissue ⬇️

artículo científico publicado el 30 de agosto de 2011

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

artículo científico publicado en 2005

Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG

artículo científico publicado el 1 de enero de 1979

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

artículo científico publicado en 2014

Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging

artículo científico publicado en 2009

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

artículo científico publicado en 2017

Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.

artículo científico publicado en 2005

Two‐Phase Designs to Follow‐Up Genome‐Wide Association Signals With DNA Resequencing Studies ⬇️

artículo científico publicado el 24 de enero de 2013

Urine Biomarkers of Risk in the Molecular Etiology of Breast Cancer ⬇️

artículo científico publicado el 6 de enero de 2009

Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies

artículo científico publicado en 2011

Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas

artículo científico publicado en 2004

VP-16, Cyclophosphamide, Adriamycin and Cis-platinum (V:CAP-I) in Patients with Metastatic Adenocarcinoma of the Lung ⬇️

artículo científico publicado el 28 de febrero de 1979

VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung

artículo científico publicado el 1 de mayo de 1978

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

artículo científico publicado en 2010

Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.

artículo científico publicado en 2017

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer

artículo científico publicado en 1990

ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion

artículo científico publicado en 2021

cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung

artículo científico publicado el 1 de agosto de 1978

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy

artículo científico publicado en 2006

p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).

artículo científico publicado en 2011

p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis

artículo científico publicado en 1994

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda